Production of Monoclonal Antibodies Specific to FimA of Porphyromonas gingivalis and Their Inhibitory Activity on Bacterial Binding
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: The FimA of Porphyromonas gingivalis is a crucial pathogenic component of the bacteria and has been implicated as a target for vaccine development against the periodontal diseases. Methods: In this study, the purified fimbriae (FimA subunit polymers) protein was used for immunization in their native form and B hybridoma clones producing antibodies specific to FimA were established. Results: The monoclonal antibodies prepared from selected two clones, designated #123 (IgG2b/ kappa) and #265 (IgG1/kappa), displayed different patterns of binding activity against the cognate antigen. Both antibodies reacted with conformational epitopes expressed by partially dissociated oligomers, but not with monomer as elucidated by Western blot analysis. Ascites fluid containing the monoclonal antibodies showed the inhibitory activity against P. gingivalis to saliva- coated hydroxyapatite beads, an in vitro model for the pellicle-coated tooth surface. Conclusion: These results suggest that the monoclonal antibodies could be used as vaccine material against the periodontal diseases through passive immunization.
Abstract
Background: The FimA of Porphyromonas gingivalis is a crucial pathogenic component of the bacteria and has been implicated as a target for vaccine development against the periodontal diseases. Methods: In this study, the purified fimbriae (FimA subunit polymers) protein was used for immunization in their native form and B hybridoma clones producing antibodies specific to FimA were established. Results: The monoclonal antibodies prepared from selected two clones, designated #123 (IgG2b/ kappa) and #265 (IgG1/kappa), displayed different patterns of binding activity against the cognate antigen. Both antibodies reacted with conformational epitopes expressed by partially dissociated oligomers, but not with monomer as elucidated by Western blot analysis. Ascites fluid containing the monoclonal antibodies showed the inhibitory activity against P. gingivalis to saliva- coated hydroxyapatite beads, an in vitro model for the pellicle-coated tooth surface. Conclusion: These results suggest that the monoclonal antibodies could be used as vaccine material against the periodontal diseases through passive immunization.
참고문헌 (22)
- Andrian E, "Porphyromonas gingivalis-epithelial cell interactions in periodontitis", J Dent Res, 85, pp.392~403 (2006)
- Griffen AL, "Prevalence of porphyromonas gingivalis and periodontal health status", J Clin Microbiol, 36, pp.3239~3242 (1998)
- Amano A, "Molecular interaction of Porphyromonas gingivalis with host cells: implication for the microbial pathogenesis of periodontal disease", J Periodontol, 74, pp.90~96 (2003)
- Ezzo PJ, "Microorganisms as risk indicators for periodontal disease", Periodontol 2000, 32, pp.24~35 (2003)
- Shibata Y, "Construction of novel human monoclonal antibodies neutralizing Porphyromonas gingivalis hemagglutination activity using transgenic mice expressing human Ig loci", Vaccine, 23, pp.3850~3856 (2005)
- Jotwani R, "Fimbriated porphyromonas gingivalis is more efficient than fimbria-deficient P. gingivalis in entering human dendritic cells in vitro and induces an inflammatory Th1 effector response", Infect Immun, 72, pp.1725~1732 (2004)
- Sharma A, "Oral immunization with recombinant streptococcus gordonii expressing porphyromonas gingivalis FimA domains", Infect Immun, 69, pp.2928~2934 (2001)
- Shin EA, "Synthesis and assembly of an adjuvanted Porphyromonas gingivalis fimbrial antigen fusion protein in plants", Protein Expr Purif, 47, pp.99~109 (2006)
- Takahashi Y, "Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit", Oral Microbiol Immunol, 22, pp.374~380 (2007)
- Evans RT, "Immunization with fimbrial protein and peptide protects against Porphyromonas gingivalis-induced periodontal tissue destruction", Adv Exp Med Biol, 327, pp.255~262 (1992)
- Evans RT, "Immunization with Porphyromonas (Bacteroides) gingivalis fimbriae protects against periodontal destruction", Infect Immun, 60, pp.2926~2935 (1992)
- Hamada N, "Construction and characterization of a fimA mutant of Porphyromonas gingivalis", Infect Immun, 62, pp.1696~1704 (1994)
- Isogai H, "Specific inhibition of adherence of an oral strain of Bacteroides gingivalis 381 to epithelial cells by monoclonal antibodies against the bacterial fimbriae", Arch Oral Biol, 33, pp.479~485 (1988)
- Casadevall A, "Passive antibody administration (immediate immunity) as a specific defense against biological weapons", Emerg Infect Dis, 8, pp.833~841 (2002)
- Ma JK, "An investigation into the mechanism of protection by local passive immunization with monoclonal antibodies against Streptococcus mutans", Infect Immun, 58, pp.3407~3414 (1990)
- Lee JY, "Purification of major fimbrial proteins of Porphyromonas gingivalis", Protein Expr Purif, 6, pp.496~500 (1995)
- Lee JY, "Synthetic peptides analogous to the fimbrillin sequence inhibit adherence of Porphyromonas gingivalis", Infect Immun, 60, pp.1662~1670 (1992)
- Kirakodu SS, "Optimizing qPCR for the quantification of periodontal pathogens in a complex plaque biofilm", Open Dent J, 2, pp.49~55 (2008)
- Hosogi Y, "Gene expression in Porphyromonas gingivalis after contact with human epithelial cells", Infect Immun, 73, pp.2327~2335 (2005)
- Dickinson DP, "Molecular cloning and sequencing of the gene encoding the fimbrial subunit protein of Bacteroides gingivalis", J Bacteriol, 170, pp.1658~1665 (1988)
- Ito HO, "Immunodominance of conformation-dependent B-cell epitopes of protein antigens", Biochem Biophys Res Commun, 308, pp.770~776 (2003)
- Yoshimura F, "Detection of specific antibodies against fimbriae and membrane proteins from the oral anaerobe Bacteroides gingivalis in patients with periodontal diseases", Microbiol Immunol, 31, pp.935~941 (1987)